Research Article

Vessel Wall-Derived Mesenchymal Stromal Cells Share Similar Differentiation Potential and Immunomodulatory Properties with Bone Marrow-Derived Stromal Cells

Figure 4

Immunomodulatory effect of SV- and BM-MSCs in vitro. Fold change in PBMCs’ proliferation showed that bone marrow- and vessel wall-derived MSCs were capable to inhibit the proliferation of lymphocytes activated by either PHA or ConA in vitro; however, statistically significant reductions in BrDU incorporation were observed only in the case of PHA. (Data shown are , ; .)